4//SEC Filing
Gangloff Scott A. 4
Accession 0000950170-24-051488
CIK 0001744659other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 7:36 PM ET
Size
5.4 KB
Accession
0000950170-24-051488
Insider Transaction Report
Form 4
Gangloff Scott A.
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-29+225,000→ 225,000 totalExercise: $19.62Exp: 2034-04-28→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Twenty-five (25) percent of the shares subject to this option shall vest and become exercisable on April 29, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001663253
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 7:36 PM ET
- Size
- 5.4 KB